Exploratory Study of NS-065/NCNP-01 in DMD

NCT02081625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: NS-065/NCNP-01

Sponsor

National Center of Neurology and Psychiatry, Japan

Collaborators

[object Object]